PPT Slide

Inhalation: Foradil (Novartis)

• Formoterol: fast-onset and long acting bronchodilator for asthma in SkyHaler, amulti-dose dry powder inhaler

• World-wide estimate: $600 million

• Novartis market research demonstrated SkyHaler the most frequent 1st choice
  • all countries
  • all age groups except the 65+ years (2nd to TH, 26% vs 29%)
  • both sexes
  • mild/moderate and severe sufferers

• Ongoing Phase III trials

• Anticipate US & European launchesin 2003 

Previous slide

Next slide

Back to first slide

View graphic version